|View printer-friendly version|
|October 06, 2005 11:45 a.m.|
|Teva Announces Approval of Glimepiride Tablets|
Jerusalem, Israel, October 6, 2005 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Glimepiride Tablets, 1 mg, 2 mg and 4 mg. Shipment of this product will begin immediately.